MALAT1在颅内动脉瘤炎症反应中的表达效应
The Expression Effect of MALAT1 in the Inflammatory Response of Intracranial Aneurysm
DOI: 10.12677/acm.2025.15113148, PDF,    科研立项经费支持
作者: 卢瑞斌:赣南医科大学第一临床医学院,江西 赣州;欧阳奕安*:赣南医科大学第一附属医院神经外科,江西 赣州
关键词: 颅内动脉瘤转移相关肺腺癌转录本-1炎症反应表达效应Intracranial Aneurysm Metastasis-Associated Lung Adenocarcinoma Transcript-1 Inflammatory Response Expression Effect
摘要: 目的:探讨长链非编码RNA转移相关肺腺癌转录本-1 (Metastasis-associated lung adenocarcinoma transcript-1, MALAT1)在颅内动脉瘤(Intracranial aneurysm, IA)炎症反应的表达效应及潜在作用。方法:收集临床IA患者的组织标本,并建立大鼠IA实验模型,通过荧光定量PCR检测MALAT1表达水平及WB检测相关炎症因子(MyD88, IL-6, TNF-α, NF-κB),系统分析MALAT1及这些炎症因子在IA组织与非IA组织中的差异表达特征。结果:人体组织中,与非IA组相比,IA组MALAT1表达显著上调(P = 0.0005);动物实验模型中,与假手术组比较,模型组大鼠IA组织MALAT1表达水平升高(P = 0.001),且MyD88、IL-6、TNF-α、NF-κB炎症因子在动物实验模型中的表达较正常血管组织显著上调(P < 0.0001, P = 0.0132, P = 0.0006, P = 0.0005)。结论:MALAT1在IA组织中高度表达,并与MyD88等炎症因子在颅内动脉瘤中的表达水平呈正相关,这表明MALAT1可能参与了IA炎症反应的表达调控。
Abstract: Objective: To investigate the expression effects and potential roles of the long non-coding RNA MALAT1 in the inflammatory response of intracranial aneurysm (IA). Methods: Tissue specimens from clinical IA patients were collected, and a rat IA experimental model was established. The expression levels of MALAT1 were detected by qPCR, and related inflammatory factors (MyD88, IL-6, TNF-α, NF-κB) were measured by Western blot (WB). Systematic analysis was conducted to compare the differential expression characteristics of MALAT1 and these inflammatory factors between IA and non-IA tissues. Results: In human tissues, MALAT1 expression was significantly upregulated in the IA group compared to the non-IA group (P = 0.0005). In animal experimental models, MALAT1 expression levels were elevated in the IA tissues of rats in the model group compared to the sham surgery group (P = 0.001), and the expression levels of inflammatory factors such as MyD88, IL-6, TNF-α, and NF-κB inflammatory factors were significantly up-regulated in the animal experimental model compared with normal vascular tissue (P < 0.0001, P = 0.0132, P = 0.0006, P = 0.0005). Conclusion: MALAT1 is highly expressed in IA tissue and positively correlates with the expression levels of inflammatory factors such as MyD88 in intracranial aneurysms, suggesting that MALAT1 may be involved in the expression regulation of the inflammatory response in IA.
文章引用:卢瑞斌, 欧阳奕安. MALAT1在颅内动脉瘤炎症反应中的表达效应[J]. 临床医学进展, 2025, 15(11): 693-701. https://doi.org/10.12677/acm.2025.15113148

参考文献

[1] Tian, Z., Wu, X., Zhang, B., Li, W. and Wang, C. (2024) Transcription Factor CEBPB Mediates Intracranial Aneurysm Rupture by Inflammatory and Immune Response. CNS Neuroscience & Therapeutics, 30, e14603. [Google Scholar] [CrossRef] [PubMed]
[2] Jiang, Z.X., Huang, J.X., You, L.T., et al. (2021) Pharmacological Inhibition of STAT3 by BP1-102 Inhibits Intracranial Aneurysm Formation and Rupture in Mice through Modulating Inflammatory Response. Pharmacology Research & Perspectives, 9, e00704. [Google Scholar] [CrossRef] [PubMed]
[3] Xu, W.W., Jin, J., Wu, X.Y., et al. (2022) MALAT1-Related Signaling Pathways in Colorectal Cancer. Cancer Cell International, 22, Article No. 126. [Google Scholar] [CrossRef] [PubMed]
[4] Xu, L., Hu, L., Hu, C., Liu, J., Li, B., Liao, X., et al. (2021) Associations between Inflammatory Cytokine Gene Polymorphisms and Susceptibilities to Intracranial Aneurysm in Chinese Population. BioMed Research International, 2021, Article 8865601. [Google Scholar] [CrossRef] [PubMed]
[5] Joanna, K., Mateusz, M., Agnieszka, Ć., et al. (2022) Pro-Inflammatory and Anti-Inflammatory Cytokines Levels are Significantly Altered in Cerebrospinal Fluid of Unruptured Intracranial Aneurysm (UIA) Patients. Journal of Inflammation Research, 2022, 156245-156261.
[6] Chen, C., Tang, F., Zhu, M., et al. (2024) Role of Inflammatory Mediators in Intracranial Aneurysms: A Review. Clinical Neurology and Neurosurgery, 242, Article 108329.
[7] Lan, S.Y., Hyun, T.K., Hyun, Y.H., et al. (2021) Transcriptomic Analysis and Competing Endogenous RNA Network in the Human Endometrium between Proliferative and Mid-Secretory Phases. Experimental and Therapeutic Medicine, 21, 1-16.
[8] Robert, P., Gilbert, Z. and Dorota, K.R. (2022) Role of Long Intergenic Noncoding RNAs in Cancers with an Overview of MicroRNA Binding. Molecular Diagnosis & Therapy, 27, 29-47.
[9] Geng, X., Zou, Y., Li, S., Qi, R., Yu, H. and Li, J. (2023) MALAT1 Mediates Α-Synuclein Expression through Mir-23b-3p to Induce Autophagic Impairment and the Inflammatory Response in Microglia to Promote Apoptosis in Dopaminergic Neuronal Cells. Mediators of Inflammation, 2023, 1-17. [Google Scholar] [CrossRef] [PubMed]
[10] Xu, J., Zhang, Q., Wang, R. and Yang, J. (2025) DNA Hypomethylated Modified LncRNA MALAT1 Promotes Atherosclerotic Cardiovascular Disease Progression through Nf-Κb Signaling Pathway Regulating Cholesterol Metabolism and Inflammatory Response. Biochemistry and Biophysics Reports, 43, Article 102173. [Google Scholar] [CrossRef] [PubMed]
[11] Yang, X.R., Zhang, Q.N., Lu, H., et al. (2021) Suppression of LncRNA MALAT1 Reduces LPS-or IL-17A-Induced Inflammatory Response in Human Middle Ear Epithelial Cells via the N-κB Signaling Pathway. BioMed Research International, 2021, Article 8844119. [Google Scholar] [CrossRef] [PubMed]
[12] Ouyang, Y., Jiang, Y.G., Yu, M.Q., et al. (2017) Upregulation of MALAT1 Expression Predicts a Poor Prognosis in the Development of Intracranial Aneurysm (IA). International Journal of Clinical and Experimental Pathology, 10, 5907-5912.
[13] Puthanveetil, P., Chen, S., Feng, B., Gautam, A. and Chakrabarti, S. (2015) Long Non‐Coding RNA MALAT1 Regulates Hyperglycaemia Induced Inflammatory Process in the Endothelial Cells. Journal of Cellular and Molecular Medicine, 19, 1418-1425. [Google Scholar] [CrossRef] [PubMed]
[14] Yan, W., Wanpin, N., Kai, Y., et al. (2016) Interleukin 6 Induces Expression of NADPH Oxidase 2 in Human Aortic Endothelial Cells via Long Noncoding RNA MALAT1. Die Pharmazie, 71, 592-597.
[15] Lino Cardenas, C.L., Kessinger, C.W., Cheng, Y., MacDonald, C., MacGillivray, T., Ghoshhajra, B., et al. (2018) An HDAC9-MALAT1-BRG1 Complex Mediates Smooth Muscle Dysfunction in Thoracic Aortic Aneurysm. Nature Communications, 9, Article No. 1009. [Google Scholar] [CrossRef] [PubMed]
[16] Zhang, X., Tang, X., Liu, K., Hamblin, M.H. and Yin, K. (2017) Long Noncoding RNA Malat1 Regulates Cerebrovascular Pathologies in Ischemic Stroke. The Journal of Neuroscience, 37, 1797-1806. [Google Scholar] [CrossRef] [PubMed]
[17] Mitsui, K., Ikedo, T., Kamio, Y., Furukawa, H., Lawton, M.T. and Hashimoto, T. (2020) TLR4 (Toll-Like Receptor 4) Mediates the Development of Intracranial Aneurysm Rupture. Hypertension, 75, 468-476. [Google Scholar] [CrossRef] [PubMed]
[18] Wen, Q., Zhan, B., Jin, L., Peng, Z., Liu, J., Zhu, L., et al. (2024) Chlojaponilactone B Attenuates THP-1 Macrophage Pyroptosis by Inhibiting the TLR/MyD88/NF-κB Pathway. Pharmaceuticals, 17, Article 402. [Google Scholar] [CrossRef] [PubMed]